Tenet Healthcare Stock
Price
Target price
€163.00
€163.00
-0.630%
-1.0
-0.630%
€176.55
03.02.26 / Tradegate
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tenet Healthcare Stock
The price for the Tenet Healthcare stock decreased slightly today. Compared to yesterday there is a change of -€1.000 (-0.630%).
With 43 Buy predictions and not a single Sell prediction Tenet Healthcare is an absolute favorite of our community.
With a target price of 176 € there is a slightly positive potential of 7.98% for Tenet Healthcare compared to the current price of 163.0 €.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | -0.630% | 0.000% | -5.882% | 17.647% | -8.046% | 209.717% | 288.491% |
| Select Medical Holdings | 0.800% | -1.600% | 0.820% | -35.263% | -1.600% | -54.779% | -45.575% |
| Chemed Corp. | -1.680% | -5.348% | -1.667% | -34.444% | -2.747% | - | - |
| Molina Healthcare | -1.300% | -9.217% | 0.920% | -48.646% | 5.240% | -45.898% | -14.639% |
Comments
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for THC provided by MarketBeat